ACT Brief: CNPV Program Operational Realities, Statistician Collaboration in Complex Trials, and GLP-1 Market Concentration

In today's ACT Brief, we examine what succeeding under compressed FDA review timelines requires, why statistician collaboration is essential as trial complexity grows, and GLP-1s reshaping pharma portfolio strategy.